CD8A and metabolic dysfunction-associated steatohepatitis: Application of β-cryptoxanthin helps to inhibit the recruitment of CD4+ and CD8+ T cells in the liver, attenuate insulin resistance and excessive lipid accumulation and peroxidation in the liver, and ultimately prevent or reverse inflammation and fibrosis in MASH (Ni et al., 2015a).